YARROW BIOSCIENCE, INC. Other Comprehensive Income (Loss), Net of Tax
YARROW BIOSCIENCE, INC. (YARW) reported Other Comprehensive Income (Loss), Net of Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was $0.00.
- YARROW BIOSCIENCE, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$2.00K.
- YARROW BIOSCIENCE, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was -$2.00K, a 116.67% decline year-over-year.
- YARROW BIOSCIENCE, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-03-31 was -$20.00K.
- YARROW BIOSCIENCE, INC. other comprehensive income (loss), net of tax for fiscal 2023 was $26.00K.
- YARROW BIOSCIENCE, INC. other comprehensive income (loss), net of tax for fiscal 2022 was $0.00.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | -$2.00K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | -$2.00K S-4/A · filed 2026-06-03 | |||
| 2025-12-31 | -$18.00K S-4/A · filed 2026-06-03 | |||
| 2025-06-30 | -$2.00K 10-Q · filed 2026-08-13 | -$22.00K 10-Q · filed 2026-08-13 | -$36.00K derived: sum of 3 quarters · filed 2026-08-13 | $56.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$20.00K S-4/A · filed 2026-06-03 | -$34.00K derived: sum of 2 quarters · filed 2026-06-03 | $58.00K derived: sum of 3 quarters · filed 2026-06-03 | $70.00K derived: sum of 4 quarters · filed 2026-06-03 |
| 2024-12-31 | -$14.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-06-03 | $78.00K derived: sum of 2 quarters · filed 2026-06-03 | $90.00K derived: sum of 3 quarters · filed 2026-06-03 | -$6.00K S-4/A · filed 2026-06-03 |
| 2024-09-30 | $92.00K 10-Q · filed 2024-11-07 | $104.00K derived: sum of 2 quarters · filed 2025-08-14 | $8.00K 10-Q · filed 2024-11-07 | $34.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | $12.00K 10-Q · filed 2025-08-14 | -$84.00K 10-Q · filed 2025-08-14 | -$58.00K derived: sum of 3 quarters · filed 2025-08-14 | -$58.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$96.00K 10-Q · filed 2025-05-08 | -$70.00K derived: sum of 2 quarters · filed 2025-05-08 | -$70.00K derived: sum of 3 quarters · filed 2025-05-08 | -$70.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $26.00K derived: sum of 2 quarters · filed 2025-03-06 | $26.00K derived: sum of 3 quarters · filed 2025-03-06 | $26.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |